Cancer cell international

Hedgehog signaling controls MGMT levels and resistance to temozolomide in human brain tumors

Updated

Abstract

O-Methylguanine DNA methyltransferase-positive glioblastoma tissues had a 67.7% rate of Gli1 nuclear staining.

  • Higher Gli1 nuclear staining is associated with O-Methylguanine DNA methyltransferase-positive glioblastoma tissues compared to negative ones.
  • Activation of the Hedgehog/Gli1 signaling pathway increases MGMT expression and reduces sensitivity to temozolomide treatment.
  • Inhibiting Hedgehog/Gli1 signaling decreases MGMT expression and enhances sensitivity to temozolomide treatment.
  • Changes in MGMT levels occur without altering the methylation status of the MGMT promoter.
  • A potential Gli1 binding site was identified in the MGMT gene promoter region at -411 to -403 bp upstream of the transcriptional start site.
  • The combination of cyclopamine and temozolomide shows a synergistic effect in inhibiting tumor growth in vivo.

Simplified

Full Text

We can’t show the full text here under this license.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free